Clinical Trials Browser

Phase 2 × Unknown × Esophageal Neoplasms × Clear all

NCT06231680 2024-03-29

Thalidomide Prevention or Treatment of Camrelizumab-induced Reactive Cutaneous Capillary Endothelial Proliferation (RCCEP)

Phase 2 Unknown

GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms

NCT06198465 2024-01-10

Perioperative Adebrelimab and Chemotherapy in Esophageal and Esophagogastric Junction Carcinoma

Phase 2 Unknown

Gastrointestinal

Esophageal Neoplasms

NCT02037048 2024-01-08

FOLFOX-6 Induction Chemotherapy Followed by Esophagectomy and Post-operative Chemoradiotherapy in Patients With Esophageal Adenocarcinoma

Phase 2 Unknown

Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Neoplasms

NCT05626569 2024-01-03

Anti-PD-1 Immunotherapy Combined With SBRT for Patients With Oligometastatic ESCC

Phase 2 Unknown

Gastrointestinal

Parkinson Disease 4, Autosomal Dominant Lewy Body, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

NCT05376423 2023-11-15

To Evaluate OBI-833/OBI-821 in Patients With Locally Advanced, Globo H-Positive Esophageal Cancer for Recurrence

Phase 2 Unknown

Gastrointestinal

Esophageal Neoplasms

NCT05828381 2023-04-25

Envafolimab Combined With Abraxane and Cisplatinas as Neoadjuvant Treatment for Resectable Esophageal Cancer

Phase 2 Unknown

Gastrointestinal

Esophageal Neoplasms

NCT03399071 2023-02-21

ICONIC

Phase 2 Unknown

Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Neoplasms, Stomach Neoplasms

NCT05619016 2022-11-30

[68Ga]Ga-ABY-025 PET for Quantification of HER2-status in Solid Tumors

Phase 2 Unknown

BreastGastrointestinal

Breast Neoplasms, Esophageal Neoplasms

NCT05476380 2022-07-27

Neoadjuvant Therapy of Camrelizumab Combined With Chemotherapy for Resectable Locally Advanced Esophageal Squamous Cell Carcinoma

Phase 2 Unknown

Gastrointestinal

Esophageal Neoplasms

NCT05424432 2022-06-27

SCALE-2

Phase 2 Unknown

Gastrointestinal

Esophageal Neoplasms

NCT04390945 2022-02-03

Camrelizumab Combined With CRT for Treatment of Patients With Local Recurrence of Esophageal Cancer

Phase 2 Unknown

Gastrointestinal

Esophageal Neoplasms

NCT05183958 2022-01-11

A Multicenter, Randomized Controlled, Phase II Clinical Study of First-line Chemotherapy and Camrelizumab With or Without Radiotherapy in the Treatment of Oligometastatic Esophageal Cancer

Phase 2 Unknown

Gastrointestinal

Esophageal Neoplasms

NCT05007145 2021-12-21

REVO

Phase 2 Unknown

Gastrointestinal

Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

NCT04286958 2021-12-10

ESCC

Phase 2 Unknown

Gastrointestinal

Esophageal Neoplasms

NCT03800953 2021-09-08

The Ave-CRT Study for Newly Diagnosed Metastatic Esophageal Squamous Cell Carcinoma

Phase 2 Unknown

Gastrointestinal

Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

NCT05013697 2021-08-19

TQB2450 Solution for Injection (TQB2450)+Paclitaxel+Cisplatin ± Anlotinib in the Treatment of Esophageal Cancer.

Phase 2 Unknown

Gastrointestinal

Esophageal Neoplasms

NCT03791905 2021-03-23

PET Imaging-guided Chemoradiotherapy in Esophageal Squamous Cell Carcinoma

Phase 2 Unknown

Gastrointestinal

Esophageal Squamous Cell Carcinoma, Carcinoma, Squamous Cell, Esophageal Neoplasms

NCT04481100 2020-10-14

CCRT With Itraconazole in Locally Advanced Squamous Esophageal Cancer

Phase 2 Unknown

Gastrointestinal

Esophageal Squamous Cell Carcinoma, Esophageal Diseases, Esophageal Neoplasms

NCT04512417 2020-08-13

A Clinical Study Of Camrelizumab With Or Without Radiotherapy In The Treatment Of Esophageal Cancer

Phase 2 Unknown

Gastrointestinal

Esophageal Neoplasms

NCT04503967 2020-08-07

OASIS

Phase 2 Unknown

Gastrointestinal

Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms, Stomach Neoplasms

NCT03544723 2020-06-09

Safety and Efficacy of p53 Gene Therapy Combined With Immune Checkpoint Inhibitors in Solid Tumors.

Phase 2 Unknown

BreastDermatologicGastrointestinalGenitourinaryGynecologicLymphoidThoracic

Carcinoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Uterine Cervical Neoplasms, Esophageal Neoplasms, Hodgkin Disease, Liver Neoplasms, Lymphoma, Melanoma, Stomach Neoplasms, Carcinoma, Merkel Cell, Neoplasms, Squamous Cell, Small Cell Lung Carcinoma, Triple Negative Breast Neoplasms

NCT03139487 2020-01-06

PRIORITY

Phase 2 Unknown

GastrointestinalSarcoma

Biliary Tract Neoplasms, Duodenal Neoplasms, Esophageal Neoplasms, Gallbladder Neoplasms, Carcinoma, Hepatocellular, Pancreatic Neoplasms, Stomach Neoplasms, Cholangiocarcinoma, Gastrointestinal Stromal Tumors

NCT03985670 2019-12-12

Teripalimab Plus Chemotherapy in Local Advanced Esophageal Cancer

Phase 2 Unknown

Gastrointestinal

Carcinoma, Squamous Cell, Esophageal Neoplasms

NCT02520453 2019-12-09

Adjuvant Durvalumab for Esophageal Cancer

Phase 2 Unknown

Gastrointestinal

Esophageal Neoplasms

NCT04177875 2019-11-26

T+TP

Phase 2 Unknown

Gastrointestinal

Esophageal Neoplasms

NCT04115618 2019-10-04

SIB in Upper Thoracic Esophageal Squamous Cell Carcinoma

Phase 2 Unknown

Gastrointestinal

Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

NCT02858206 2019-07-26

Simultaneous Integrated Boost Radiotherapy and Concurrent Nimotuzumab or Chemotherapy for Esophageal Carcinoma

Phase 2 Unknown

Gastrointestinal

Esophageal Neoplasms

NCT03829345 2019-07-08

SOLAR

Phase 2 Unknown

Gastrointestinal

Esophageal Neoplasms, Stomach Neoplasms

NCT03910634 2019-04-10

IMRT With Carboplatin Versus IMRT With Carboplatin and Fluorouracil for Eldly Esophageal Cancer Patients

Phase 2 Unknown

Gastrointestinal

Esophageal Neoplasms, Radiation Injuries

NCT02177552 2019-02-15

SEED

Phase 2 Unknown

Gastrointestinal

Esophageal Neoplasms, Stomach Neoplasms

NCT02636088 2018-09-21

LERFOX-C

Phase 2 Unknown

Gastrointestinal

Esophageal Neoplasms

NCT03649945 2018-08-28

Endostatin Combined With Chemotherapy for Adjuvant Treatment of Esophageal Cancer

Phase 2 Unknown

Gastrointestinal

Esophageal Neoplasms

NCT03585673 2018-07-17

DOSE

Phase 2 Unknown

Gastrointestinal

Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms, Neoplasm Metastasis, Recurrence

NCT03579004 2018-07-06

Neoadjuvant Chemotherapy Followed by Preoperative Chemoradiation in Resectable Squamous-cell Esophageal Cancer

Phase 2 Unknown

Gastrointestinal

Esophageal Squamous Cell Carcinoma, Carcinoma, Squamous Cell, Esophageal Neoplasms

NCT02937519 2018-06-06

Chronomodulated Chemotherapy Followed by Concurrent Chemo-radiotherapy With IMRT in the Treatment of Advanced Nasopharyngeal Cancer

Phase 2 Unknown

Gastrointestinal

Esophageal Neoplasms

NCT02924909 2018-03-20

QUIMERA

Phase 2 Unknown

Gastrointestinal

Esophageal Neoplasms

NCT02545751 2017-11-28

SBRT Combined With Thymalfasin for Metastatic Esophageal Cancer

Phase 2 Unknown

Gastrointestinal

Esophageal Neoplasms

NCT01693432 2017-08-23

Docetaxel and S-1 for Advanced Esophageal Cancer

Phase 2 Unknown

Gastrointestinal

Esophageal Neoplasms

NCT03254511 2017-08-22

Addition of Enoxaparin to Neoadjuvant Chemoradiation of Esophageal Cancer

Phase 2 Unknown

Gastrointestinal

Esophageal Neoplasms

NCT03200691 2017-08-07

Neoadjuvant Anti-PD-1 Antibody SHR-1210 and Radiation in Resectable Esophageal Squamous Cell Carcinoma

Phase 2 Unknown

Gastrointestinal

Esophageal Squamous Cell Carcinoma, Esophageal Diseases, Esophageal Neoplasms

NCT02959385 2017-07-18

A Phase II Trial to Compare Efficacy and Safety of CRT VS Neo-CRT in Patients Who Achieved CCR for Esophageal Cancer

Phase 2 Unknown

Gastrointestinal

Esophageal Neoplasms

NCT02969473 2016-11-21

Definitive Concurrent Chemoradiotherapy With Docetaxel Plus Cisplatin Versus 5-fluorouracil Plus Cisplatin in Patients With Esophageal Squamous Cell Carcinoma

Phase 2 Unknown

Gastrointestinal

Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

NCT02938195 2016-10-19

Phase II Study of Neo-adjuvant Chemoradiotherapy for Squamous Cell Esophageal Cancer

Phase 2 Unknown

Gastrointestinal

Esophageal Neoplasms

NCT02544737 2016-08-26

Apatinib for Metastatic Esophageal Cancer.

Phase 2 Unknown

Gastrointestinal

Esophageal Neoplasms

NCT02644863 2016-05-24

Autologous Tumor Tissue Antigen-sensitized DC-CIK Cells Combined With Chemotherapy for Esophageal Cancer

Phase 2 Unknown

Gastrointestinal

Digestive System Neoplasms, Esophageal Neoplasms, Neoplasms

NCT02745561 2016-04-20

Endostatin in Combination With Oxaliplatin and Radiotherapy in Esophageal Cancer Patients.

Phase 2 Unknown

Gastrointestinal

Esophageal Neoplasms

NCT02375581 2016-03-22

Phase II Study of Icotinib With Concurrent Radiotherapy in Elderly Patients With Esophageal Cancer

Phase 2 Unknown

Gastrointestinal

Esophageal Neoplasms

NCT01551641 2016-02-17

Phase II Trial of Thalidomide Combined With Concurrent Chemoradiotherapy in Esophageal Cancer

Phase 2 Unknown

Gastrointestinal

Esophageal Neoplasms

NCT02683655 2016-02-17

Study of Apatinib in Metastatic Esophageal Cancer

Phase 2 Unknown

Gastrointestinal

Esophageal Neoplasms

NCT00004236 2014-06-24

Liposomal Doxorubicin in Treating Patients With Advanced Stomach Cancer

Phase 2 Unknown

Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Neoplasms, Stomach Neoplasms